Elucidating Pseudomonas aeruginosa non-canonical two component system signaling
Elucidating Pseudomonas aeruginosa non-canonical two component system signaling
批准号:
8224251
负责人:
DEBORAH T HUNG
金额:
$26.19万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-03-01 至 2014-02-28
关键词:
AcuteAntibiotic ResistanceAntibioticsAttentionBacteriaBacterial ProteinsBiochemicalBiochemical GeneticsCandidate Disease GeneChronicClinicalComplexDevelopmentDiseaseEmbryoEnvironmentEvaluationEventGenesGeneticGenetic SuppressionGrowthHealthHumanIn VitroInfectionLife StyleMediatingModelingMolecularMolecular ProfilingPhenocopyPhenotypePhosphorylationPhosphotransferasesPlayPrevalenceProcessProteinsPseudomonas aeruginosaReporterRoleScreening procedureSignal TransductionSystemTestingTherapeuticValidationVirulenceZebrafishcandidate identificationcombatgenetic selectionin vivoinhibitor/antagonistinsightmutantnovelnovel strategiesnovel therapeuticspathogenprotein-histidine kinaseresponsesensorsensor histidine kinase
中文摘要
描述(由申请人提供):在临床上重要的病原体中,抗生素耐药性的日益普遍是一个日益增长的威胁,超过了具有新的作用机制的抗生素的发展。一种新的方法引起了越来越多的关注,那就是针对细菌的毒力。一类有吸引力的靶标是双组分系统(TCSs),它感知环境的变化并协调细胞反应。这些细菌靶点在感染过程中很重要,而在哺乳动物宿主中则不存在。此外,tcs通常跨物种保守,因此抑制剂可能具有广谱活性。
英文摘要
DESCRIPTION (provided by applicant): The increasing prevalence of antibiotic resistance among clinically important pathogens is a growing threat, outpacing the development of antibiotics with new mechanisms of action. One novel approach that has drawn increasing attention is targeting bacterial virulence. One attractive class of targets is two component systems (TCSs), which sense changes in the environment and coordinate a cellular response. These bacterial targets are important during infection while absent in mammalian hosts. Moreover, TCSs are often conserved across species so that inhibitors would have the potential to be broad spectrum in activity.
Pseudomonas aeruginosa, an important clinical pathogen with increasing antibiotic resistance, encodes one of the largest sets of TCSs known in bacteria and is thought to use these TCSs to coordinate the transition between growth in the external environment and in a human host, including the transition from acute to chronic infection lifestyles. It is becoming increasingly clear that TCS signaling is highly complex in P. aeruginosa. While canonical TCS signaling, defined as phosphorylation of a response regulator by its cognate histidine sensor kinase, is important, increasing evidence suggests that non-canonical TCS signaling may be equally important. Non-canonical signaling includes a number of different signaling mechanisms such as 1. physical interactions between sensors rather than phosphorylation events to modulate the activity of a response regulator, 2. signaling of a sensor through an alternative response regulator, or 3. signaling through multiple response regulators by one sensor kinase (cross-talk).
We have identified several novel TCS not previously known to play a role in acute infection by screening a comprehensive set of P. aeruginosa mutants in 58 TCS sensor kinases in a new vertebrate model of acute infection. We identified kinB, phoR, bqsS, and copS as being required for full virulence in Danio rerio (zebrafish) embryos as well as gacS and retS, which have previously been shown to be required for infection in other models. We found that while KinB is required for acute infection, it signals non-canonically, independent both of its cognate response regulator, AlgB, and of its kinase activity. We propose to elucidate the mechanism of KinB's non-canonical TCS signaling and define the degree of non-canonical TCS signaling for the three other novel TCS (PhoR, BqsS, and CopS). Understanding the extent of non-canonical TCS signaling and the degree of cross-talk among TCS sensors and response regulators during acute vertebrate infection is critical for evaluating the potential of targeting TCS as a therapeutic strategy and will provide insight into the mechanisms that pathogens use to adapt to varying environments, including the human host to elicit disease.
PUBLIC HEALTH RELEVANCE: Understanding how bacterial pathogens such as Pseudomonas aeruginosa sense and respond to their environments, including the human host, is critical to understanding how they adapt to the host microenvironment and cause disease. We have identified several Pseudomonas aeruginosa signaling systems called two component systems that are required to cause lethality in a vertebrate host model. We propose to elucidate the mechanisms by which they transduce these signals through intracellular response regulators; therefore, by understanding such molecular processes, we will evaluate the potential new paradigm of targeting such bacterial factors as a new therapeutic strategy in this current era of increasing antibiotic resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
-
批准号:10670196
-
项目类别:
-
资助金额:$125.74万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 1 Genomic applications to transform Gram-negative Antibiotic discovery
-
批准号:10670186
-
项目类别:
-
资助金额:$221.47万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery.
-
批准号:10670154
-
项目类别:
-
资助金额:$649.55万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Administrative Core
-
批准号:10670185
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery.
-
批准号:10242000
-
项目类别:
-
资助金额:$673.54万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
-
批准号:10463692
-
项目类别:
-
资助金额:$119.4万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
-
批准号:10242006
-
项目类别:
-
资助金额:$145.31万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Administrative Core
-
批准号:10463687
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 1 Genomic applications to transform Gram-negative Antibiotic discovery
-
批准号:10242002
-
项目类别:
-
资助金额:$187.02万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Project 1 Genomic applications to transform Gram-negative Antibiotic discovery
-
批准号:10463688
-
项目类别:
-
资助金额:$185.21万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery.
-
批准号:10463686
-
项目类别:
-
资助金额:$662.11万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
Innovative technologies to transform antibiotic discovery. Administrative Core
-
批准号:10242001
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2019
-
负责人:DEBORAH T HUNG
-
依托单位:
New targets against tuberculosis
-
批准号:10197774
-
项目类别:
-
资助金额:$107.68万
-
财政年份:2017
-
负责人:DEBORAH T HUNG
-
依托单位:
RNA based diagnostics for rapid pathogen identification and drug resistance
-
批准号:9210598
-
项目类别:
-
资助金额:$123.94万
-
财政年份:2015
-
负责人:DEBORAH T HUNG
-
依托单位:
Exploiting bacterial uptake as a universal platform for antibacterial development
-
批准号:9096697
-
项目类别:
-
资助金额:$24.52万
-
财政年份:2015
-
负责人:DEBORAH T HUNG
-
依托单位:
RNA based diagnostics for rapid pathogen identification and drug resistance
-
批准号:8876094
-
项目类别:
-
资助金额:$155.26万
-
财政年份:2015
-
负责人:DEBORAH T HUNG
-
依托单位:
Development of a small molecule probe targeting non-replicating M. tuberculosis
-
批准号:8874103
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2014
-
负责人:DEBORAH T HUNG
-
依托单位:
Development of a small molecule probe targeting non-replicating M. tuberculosis
-
批准号:8747598
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2014
-
负责人:DEBORAH T HUNG
-
依托单位:
A "radical" approach to tuberculosis infection
-
批准号:9249466
-
项目类别:
-
资助金额:$54.9万
-
财政年份:2013
-
负责人:DEBORAH T HUNG
-
依托单位:
A "radical" approach to tuberculosis infection
-
批准号:9040078
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2013
-
负责人:DEBORAH T HUNG
-
依托单位:
海外基金